Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 years or older
- People with a general health status rated as ECOG 2 or below (a scale used to measure how much a person's cancer affects their daily activities — confirm with trial site if unsure what this means for a specific situation)
- People who have been diagnosed with primary breast cancer confirmed by laboratory testing, and whose cancer has come back or spread to other parts of the body, confirmed by laboratory or imaging tests
- People whose breast cancer falls into one of these categories based on tumour markers: HR+/HER2+, HR-/HER2+, or HR-/HER2- (these refer to specific proteins found on cancer cells — the trial site can explain which category applies)
- People who have at least one measurable area of cancer, or cancer that has spread only to bones (in a dissolving or mixed pattern), as assessed by standard imaging guidelines
- People whose cancer responded to or stabilised with previous treatment (meaning the cancer showed complete response, partial response, or stable disease)
- People with an expected survival of at least 6 months
- People with adequate organ function (meaning the liver, kidneys, and other organs are working well enough — the trial site will assess this)
Who may not be able to join:
- People who are currently pregnant or breastfeeding
- People whose cancer has spread to the central nervous system (the brain or spinal cord)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wenjin Yin, M.D., Renji Hospital,School of Medicine, Shanghai Jiaotong University
Phone: 86(21)68385569
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-Free Survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.